Promising Flavonoid‐Fused Aminoquinolines as Synthetic Alzheimer's Disease Models: Design, Synthesis, Anticholinesterase Activity, ADMET and Molecular Docking
ChemBioChem · 27.05.2026 · 27 (10)
DOI: 10.1002/cbic.70391 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 25.05.2026. Verfasst von Inaiá O Rocha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo de Química de Heterociclos (NUQUIMHE), Department of Chemistry, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Molecular Docking Simulation, Alzheimer Disease, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Instituto Federal Sul-riograndense, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Themen: Demenz
Abstract (Originalsprache)
An efficient one‐pot, two‐step [4 + 2] cyclocondensation reaction of (±)‐2‐phenylchroman‐4‐ones ( 1 ) with various scaffolds of 2‐aminobenzonitriles ( 2 ) was employed using AlCl 3 as the catalyst in the presence of toluene as a solvent under conventional thermal heating. This method was used to synthesize a series of six novel examples of (±)‐7‐amino‐6‐aryl‐6 H ‐chromeno[4,3‐ b ]quinolines ( 3 ), which were designed as potential cholinesterase inhibitors. Subsequently, the new chromeno[4,3‐ b ]quinolines were evaluated for their AChE and BChE inhibitory activity and subjected to molecular docking studies. In vitro cholinesterase assays and in silico docking demonstrated that all newly modified tacrine analogs 3 exhibited higher Hs BChE inhibitory activity compared to Hs AChE. Specifically, the most effective human cholinesterase inhibitor was the compound (±)‐7‐amino‐6‐phenyl‐6 H ‐chromeno[4,3‐ b ]quinoline ( 3aa ), with an IC 50 of 2.73 μM for Hs AChE and 0.096 μM for Hs BChE. These findings suggest that compound 3aa is a promising candidate for further assessment in synthetic Alzheimer's disease models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Núcleo de Química de Heterociclos (NUQUIMHE), Department of Chemistry, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
- Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
- Federal Institute of Southern Rio Grande do Sul (IFSul), Bagé, Rio Grande do Sul, Brazil.
- Biological Science Graduate Program: Toxicological Biochemistry, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
ORCID-Profile: Helio G Bonacorso
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Instituto Federal Sul-riograndense
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- CAPES Foundation
- CNPq
Zitieren
APA
Rocha, I. O., Delgado, C. P., Nogara, P. A., Rocha, J. B. T., Martins, M. A. P., Zanatta, N., & Bonacorso, H. G. (2026). Promising Flavonoid‐Fused Aminoquinolines as Synthetic Alzheimer's Disease Models: Design, Synthesis, Anticholinesterase Activity, ADMET and Molecular Docking. ChemBioChem, 27(10). https://doi.org/10.1002/cbic.70391
Vancouver
Rocha IO, Delgado CP, Nogara PA, Rocha JBT, Martins MAP, Zanatta N, et al. Promising Flavonoid‐Fused Aminoquinolines as Synthetic Alzheimer's Disease Models: Design, Synthesis, Anticholinesterase Activity, ADMET and Molecular Docking. ChemBioChem. 2026;27(10). doi:10.1002/cbic.70391
BibTeX
@article{Rocha2026,
author = {Rocha, Inaiá O and Delgado, Cássia P and Nogara, Pablo A and Rocha, João B T and Martins, Marcos A P and Zanatta, Nilo and Bonacorso, Helio G},
title = {Promising Flavonoid‐Fused Aminoquinolines as Synthetic Alzheimer's Disease Models: Design, Synthesis, Anticholinesterase Activity, ADMET and Molecular Docking},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {10},
doi = {10.1002/cbic.70391}
}
EUVIMED